| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |